Liquid Biopsy Market Projected to Reach USD 21.78 Billion by 2032 Amid Rising Demand for Non-Invasive Cancer Diagnostics – SNS Insider [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Pune, March 20, 2025 (GLOBE NEWSWIRE) -- Liquid Biopsy Market Size & Growth Analysis: According to SNS Insider, the global liquid biopsy market , which was valued at USD 7.20 billion in 2023, is anticipated to expand to USD 21.78 billion by 2032. This projection reflects a compound annual growth rate of 13.11% over the forecast period from 2024 to 2032. Liquid biopsy, a minimally invasive diagnostic method, identifies circulating tumor cells (CTCs), cell-free nucleic acids, and exosomes in body fluids and provides a holistic genomic portrait of tumors without requiring conventional tissue biopsies. This method enables early cancer diagnosis, monitoring of treatment response, and detection of therapeutic targets, thus improving personalized me
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health, Inc. (NASDAQ: GH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $55.00 price target on the stock.MarketBeat
- Guardant Health's Shield Blood Test Now Covered for VA Community Care Beneficiaries [Yahoo! Finance]Yahoo! Finance
- Guardant Health’s Shield Blood Test Now Covered for VA Community Care BeneficiariesBusiness Wire
- 1 Healthcare Stock on Our Watchlist and 2 to Turn Down [Yahoo! Finance]Yahoo! Finance
- Guardant Health Receives ADLT Status From CMS for Shield Blood Test [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/20/25 - Beat
GH
Sec Filings
- 4/2/25 - Form 4
- 4/2/25 - Form 4
- 4/2/25 - Form 4
- GH's page on the SEC website